HELX Holdings — Franklin Genomic Advancements ETF
All 61 reported holdings of Franklin Genomic Advancements ETF (HELX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Guardant Health Inc | 6.77% | $1.45M |
| Natera, Inc. | 6.65% | $1.43M |
| Krystal Biotech Inc | 5.32% | $1.14M |
| United Therapeutics Corporation | 4.64% | $996.21K |
| Insmed Inc | 4.52% | $970.00K |
| Bridgebio Pharma Inc | 4.22% | $905.38K |
| Ligand Pharmaceuticals Incorporated | 3.53% | $757.47K |
| AstraZeneca PLC | 3.40% | $728.73K |
| Adaptive Biotechnologies Corp | 3.12% | $669.64K |
| Vertex Pharmaceuticals Incorporated | 2.99% | $640.78K |
| Samsung Biologics Co Ltd | 2.99% | $640.23K |
| Medpace Holdings Inc. | 2.97% | $637.21K |
| Regeneron Pharmaceuticals, Inc. | 2.69% | $577.93K |
| Corteva Inc | 2.69% | $577.93K |
| Alnylam Pharmaceuticals Inc. | 2.60% | $558.18K |
| Eli Lilly & Co. | 2.54% | $545.42K |
| Ionis Pharmaceuticals, Inc. | 2.09% | $447.31K |
| Tempus AI Inc. | 1.84% | $394.59K |
| BioNTech SE | 1.80% | $385.74K |
| Neurocrine Biosciences Inc | 1.65% | $354.78K |
| Stoke Therapeutics Inc | 1.60% | $343.15K |
| Twist Bioscience Corporation | 1.59% | $341.38K |
| Argenx SE | 1.53% | $328.32K |
| PTC Therapeutics, Inc. | 1.48% | $316.94K |
| Travere Therapeutics Inc | 1.40% | $300.93K |
| Charles River Laboratories International, Inc. | 1.16% | $249.26K |
| CRISPR Therapeutics AG | 1.04% | $222.20K |
| Repligen Corporation | 1.03% | $219.85K |
| Veracyte Inc | 1.02% | $218.64K |
| Praxis Precision Medicines Inc | 1.00% | $214.90K |
| GRAIL Inc | 1.00% | $213.85K |
| Sartorius AG | 0.96% | $205.33K |
| Danaher Corporation | 0.93% | $199.08K |
| Thermo Fisher Scientific Inc | 0.90% | $192.19K |
| IQVIA Holdings Inc. | 0.80% | $171.39K |
| Beam Therapeutics, Inc. | 0.78% | $167.67K |
| Jazz Pharmaceuticals PLC | 0.74% | $158.99K |
| Catalyst Pharmaceuticals Inc. | 0.74% | $157.84K |
| Cadence Design Systems, Inc. | 0.71% | $151.44K |
| Agilent Technologies Inc. | 0.60% | $129.48K |
| Caredx Inc | 0.60% | $128.97K |
| Qiagen NV | 0.59% | $127.13K |
| AnaptysBio Inc. | 0.53% | $113.19K |
| Samsung Epis Holdings Co. Ltd. | 0.53% | $112.88K |
| Tarsus Pharmaceuticals Inc | 0.49% | $104.31K |
| Ultragenyx Pharmaceuticals Inc | 0.47% | $99.83K |
| Arcutis Biotherapeutics, Inc. | 0.45% | $96.76K |
| Axsome Therapeutics Inc. | 0.45% | $95.67K |
| GeneDx Holdings Corp | 0.42% | $90.49K |
| Rhythm Pharmaceuticals Inc | 0.40% | $84.71K |
| Hinge Health, Inc. | 0.39% | $84.14K |
| Bristol-Myers Squibb Company | 0.31% | $67.38K |
| Bio-Rad Laboratories, Inc. | 0.29% | $63.00K |
| Beone Medicines Ltd. | 0.29% | $62.07K |
| TransMedics Group Inc. | 0.22% | $47.92K |
| Neurogene Inc. | 0.17% | $37.09K |
| Wave Life Sciences Ltd. | 0.15% | $32.41K |
| Recursion Pharmaceuticals Inc | 0.15% | $31.91K |
| Caris Life Sciences Inc. | 0.05% | $9.96K |
| Omniab, Inc. | 0.00% | $0 |
| Omniab, Inc. | 0.00% | $0 |
HELX overview: performance, fees, allocation and SEC filings